OCM
REPL icon

Osterweis Capital Management’s Replimune Group REPL Stock Holding History

Osterweis Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-51,250
Closed -$877K – 213
2023
Q3 		$877K Sell
51,250
-66,605
-57% -$1.31M 0.06% 97
2023
Q2 		$2.74M Sell
117,855
-33,010
-22% -$645K 0.18% 91
2023
Q1 		$2.66M Buy
150,865
+36,835
+32% +$876K 0.18% 96
2022
Q4 		$3.1M Sell
114,030
-10,285
-8% -$214K 0.23% 91
2022
Q3 		$2.15M Sell
124,315
-14,445
-10% -$275K 0.16% 100
2022
Q2 		$2.43M Buy
138,760
+39,615
+40% +$651K 0.18% 94
2022
Q1 		$1.68M Sell
99,145
-51,615
-34% -$974K 0.09% 111
2021
Q4 		$4.09M Buy
150,760
+29,485
+24% +$882K 0.2% 94
2021
Q3 		$3.6M Sell
121,275
-24,430
-17% -$793K 0.2% 98
2021
Q2 		$5.6M Sell
145,705
-37,225
-20% -$1.27M 0.29% 94
2021
Q1 		$5.58M Buy
182,930
+107,705
+143% +$4.03M 0.3% 87
2020
Q4 		$2.87M Buy
+75,225
New +$3.13M 0.17% 94

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Osterweis Capital Management's REPL Position: Q4 2023 in Review

Osterweis Capital Management sold out of Replimune Group (REPL) in Q4 2023, closing a stake of 51,250 shares — an estimated $877K sold.

Osterweis Capital Management first reported a position in REPL in Q4 2020 and held it in 12 quarters. The position peaked at $5.6M in Q2 2021. 140 funds tracked by Wall St. Rank hold REPL as of Q4 2023.

  • Osterweis Capital Management reported no remaining Replimune Group position as of Q4 2023 after selling out during the quarter.
  • Osterweis Capital Management sold 51,250 Replimune Group shares in Q4 2023, an estimated $877K.
  • Osterweis Capital Management first reported a position in Replimune Group in Q4 2020 and held it in 12 quarters.
  • Osterweis Capital Management's Replimune Group position peaked at $5.6M in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Replimune Group as of Q4 2023.

Based on Osterweis Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.